| Market Cap | ₹2.71Cr |
| ROE | 40.51% |
| P/E Ratio(TTM) | -16.07 |
| EPS(TTM) | -0.28 |
| P/B Ratio | 0.00 |
| Dividend Yield | 0.00% |
| Industry P/E | 41.03 |
| Book Value | -0.55 |
| Debt to Equity | -0.75 |
| Face Value | 5 |
| Parent Organisation | Rekvina Laboratories Limited |
| BSE Symbol | 526075 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 60.46 | ||
| Ajanta Pharma | NA (0.00%) | 33.51 | ||
| Gland Pharma | NA (0.00%) | 40.91 | ||
| Eris Lifesciences | NA (0.00%) | 53.04 |